E. Tuzun Et Al. , "Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis," JOURNAL OF NEUROIMMUNOLOGY , vol.181, pp.29-33, 2006
Tuzun, E. Et Al. 2006. Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis. JOURNAL OF NEUROIMMUNOLOGY , vol.181 , 29-33.
Tuzun, E., SAINI, S. S., MORGAN, B. P., & CHRISTADOSS, P., (2006). Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis. JOURNAL OF NEUROIMMUNOLOGY , vol.181, 29-33.
Tuzun, Erdem Et Al. "Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis," JOURNAL OF NEUROIMMUNOLOGY , vol.181, 29-33, 2006
Tuzun, Erdem Et Al. "Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis." JOURNAL OF NEUROIMMUNOLOGY , vol.181, pp.29-33, 2006
Tuzun, E. Et Al. (2006) . "Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis." JOURNAL OF NEUROIMMUNOLOGY , vol.181, pp.29-33.
@article{article, author={Erdem TÜZÜN Et Al. }, title={Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis}, journal={JOURNAL OF NEUROIMMUNOLOGY}, year=2006, pages={29-33} }